IRENE JERNAZIAN-KANAIAN: Open Payments
NPI 1366585499 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 15 payments from 4 companies in 2025. Trend: 2023 $594 · 2024 $293 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $244 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Alkermes, Inc. | 1 | $27 |
Products named: REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR, COBENFY, ARISTADA.
Industry payments across CA — which companies pay providers there.
